Literature DB >> 11385772

Carcinoma of the ovary.

A P Heintz1, F Odicino, P Maisonneuve, U Beller, J L Benedet, W T Creasman, H Y Ngan, M Sideri, S Pecorelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11385772

Source DB:  PubMed          Journal:  J Epidemiol Biostat        ISSN： 1359-5229


× No keyword cloud information.
  22 in total

1.  Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma.

Authors:  Silvia R Graziani; Carolina G Vital; Aleksandra T Morikawa; Brigitte M Van Eyll; Hezio J Fernandes Junior; Roberto Kalil Filho; Raul C Maranhão
Journal:  Med Oncol       Date:  2017-07-29       Impact factor: 3.064

Review 2.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

3.  Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Authors:  Wenting Liu; Hiroaki Kajiyama; Kiyosumi Shibata; Yoshihiro Koya; Takeshi Senga; Fumitaka Kikkawa
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

Review 4.  Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

Authors:  José A García-Sáenz; Ana Custodio; Antonio Casado; José Antonio Vidart; Pluvio J Coronado; Miguel Martín; Sara López-Tarruella; Javier Puente; Cristina Fernández; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

Review 5.  Operative management of primary epithelial ovarian cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

6.  Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

Authors:  Radoslav Chekerov; Irina Klaman; Menelaos Zafrakas; Dominique Könsgen; Alexander Mustea; Beate Petschke; Werner Lichtenegger; Jalid Sehouli; Edgar Dahl
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

7.  Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial.

Authors:  Janina Brucker; Christine Mayer; Gerhard Gebauer; Peter Mallmann; Antje Kristina Belau; Andreas Schneeweiss; Christof Sohn; Michael Eichbaum
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

8.  Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.

Authors:  Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Toshiharu Kamura; Takahiro Kasamatsu; Yasuhiro Fujiwara
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-01       Impact factor: 4.553

9.  Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion.

Authors:  Chien-Lin Chen; Lydia W T Cheung; Man-Tat Lau; Jung-Hye Choi; Nelly Auersperg; Hsin-Shih Wang; Alice S T Wong; Peter C K Leung
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

10.  Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management.

Authors:  Vincenzo Dario Mandato; Martino Abrate; Pierandrea De Iaco; Debora Pirillo; Gino Ciarlini; Maurizio Leoni; Giuseppe Comerci; Alessandro Ventura; Bruno Lenzi; Andrea Amadori; Federica Rosati; Ruby Martinello; Rossana De Palma; Chiara Ventura; Laura Maria Beatrice Belotti; Debora Formisano; Giovanni Battista La Sala
Journal:  J Ovarian Res       Date:  2013-03-31       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.